Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the sufficient treatment of peripheral intervention by cilostazol study

Circulation

Volumn 127, Issue 23, 2013, Pages 2307-2315

  Iida, Osamu ^a   Yokoi, Hiroyoshi ^b   Soga, Yoshimitsu ^b   Inoue, Naoto ^c   Suzuki, Kenji ^c   Yokoi, Yoshiaki ^d   Kawasaki, Daizo ^e   Zen, Kan ^f   Urasawa, Kazushi ^g   Shintani, Yoshiaki ^h   Miyamoto, Akira ⁱ   Hirano, Keisuke ^j   Miyashita, Yusuke ^k   Tsuchiya, Taketsugu ^l   Shinozaki, Norihiko ^m   Nakamura, Masato ⁿ   Isshiki, Takaaki ^o   Hamasaki, Toshimitsu ^p   Nanto, Shinsuke ^p  

^a KANSAI ROSAI HOSPITAL   (Japan)

^b KOKURA MEMORIAL HOSPITAL   (Japan)

^c SENDAI KOUSEI HOSPITAL   (Japan)

^d Kishiwada Tokushukai Hospital   (Japan)

^e HYOGO COLLEGE OF MEDICINE   (Japan)

^f Department of Dermatology Omihachiman Community Medical Center   (Japan)

^g Tokeidai Memorial Hospital   (Japan)

^h Shin Koga Hospital   (Japan)

ⁱ Kikuna Memorial Hospital   (Japan)

^j SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

^k SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^l KANAZAWA MEDICAL UNIVERSITY   (Japan)

^m TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^o TEIKYO UNIVERSITY HOSPITAL   (Japan)

^p OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Angioplasty; Peripheral vascular disease; Restenosis

Indexed keywords

CILOSTAZOL;

AGED; ANGIOGRAPHY; ARTICLE; BONE LESION; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; FEMOROPOPLITEAL LESION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NITINOL STENT; OPEN STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS;

ANGIOPLASTY; PERIPHERAL VASCULAR DISEASE; RESTENOSIS;

AGED; AGED, 80 AND OVER; ALLOYS; ANGIOPLASTY; ASPIRIN; CARDIOVASCULAR DISEASES; CONSTRICTION, PATHOLOGIC; DISEASE-FREE SURVIVAL; DRUG THERAPY, COMBINATION; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION INHIBITORS; POPLITEAL ARTERY; PROSPECTIVE STUDIES; RECURRENCE; SINGLE-BLIND METHOD; STENTS; TETRAZOLES; VASODILATOR AGENTS;

EID: 84878940609     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.000711     Document Type: Article

References (22)

1. Morris-Stiff G, Ogunbiyi S, Rees J, Davies CJ, Hicks E, Lewis MH. Variations in the anatomical distribution of peripheral vascular disease according to gender. Ann R Coll Surg Engl. 2011;93:306-309.
2. Zeller T. Current state of endovascular treatment of femoro-popliteal artery disease. Vasc Med. 2007;12:223-234.
3. Balzer JO, Thalhammer A, Khan V, Zangos S, Vogl TJ, Lehnert T. Angioplasty of the pelvic and femoral arteries in PAOD: results and review of the literature. Eur J Radiol. 2010;75:48-56.
4. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31(1 pt 2):S1-S296.
5. Minar E, Pokrajac B, Maca T, Ahmadi R, Fellner C, Mittlböck M, Seitz W, Wolfram R, Pötter R. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation. 2000;102:2694-2699.
6. Krankenberg H, Schlüter M, Steinkamp HJ, Bürgelin K, Scheinert D, Schulte KL, Minar E, Peeters P, Bosiers M, Tepe G, Reimers B, Mahler F, Tübler T, Zeller T. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116:285-292.
7. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888.
8. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR; RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267-276.
9. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5-S67.
10. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V, Roffi M, Röther J, Sievert H, van Sambeek M, Zeller T; ESC Committee for Practice Guidelines. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2851-2906.
11. Hagenaars T, Gussenhoven EJ, van Sambeek MR, Jukema JW, Kranendonk SE, Bom N. Effect of simvastatin on restenosis after percutaneous transluminal angioplasty of femoropopliteal arterial obstruction. Am J Cardiol. 2000;86:774-776, A6.
12. Iida O, Nanto S, Uematsu M, Morozumi T, Kitakaze M, Nagata S. Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions. J Vasc Surg. 2008;48:144-149.
13. Soga Y, Yokoi H, Kawasaki T, Nakashima H, Tsurugida M, Hikichi Y, Nobuyoshi M. Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication. J Am Coll Cardiol. 2009;53:48-53.
14. Rocha-Singh KJ, Jaff MR, Crabtree TR, Bloch DA, Ansel G; VIVA Physicians, Inc. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv. 2007;69:910-919.
15. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Zeller T, Roubin GS, Burket MW, Khatib Y, Snyder SA, Ragheb AO, White JK, Machan LS; Zilver PTX Investigators. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4:495-504.
16. Ranke C, Creutzig A, Alexander K. Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol. 1992;18:433-440.
17. Langenberger H, Schillinger M, Plank C, Sabeti S, Dick P, Cejna M, Lammer J, Minar E, Loewe C. Agreement of duplex ultrasonography vs. computed tomography angiography for evaluation of native and instent SFA re-stenosis-findings from a randomized controlled trial. Eur J Radiol. 2012;81:2265-2269.
18. Kawarada O, Higashimori A, Noguchi M, Waratani N, Yoshida M, Fujihara M, Yokoi Y, Honda Y, Fitzgerald PJ. Duplex criteria for in-stent restenosis in the superficial femoral artery. Catheter Cardiovasc Interv. 2013;81:E199-E205.
19. Lammer J, Bosiers M, Zeller T, Schillinger M, Boone E, Zaugg MJ, Verta P, Peng L, Gao X, Schwartz LB. First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg. 2011;54:394-401.
20. O'Donnell ME, Badger SA, Sharif MA, Young IS, Lee B, Soong CV. The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease. J Vasc Surg. 2009;49:1226-1234.
21. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, Creager MA, Easton JD, Gavin JR 3rd, Greenland P, Hankey G, Hanrath P, Hirsch AT, Meyer J, Smith SC, Sullivan F, Weber MA; Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med. 2003;163:884-892.
22. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA. 1995;274:975-980.